Cowper P A, Weinberger M, Hanlon J T, Landsman P B, Samsa G P, Uttech K M, Schmader K E, Lewis I K, Cohen H J, Feussner J R
Center for Health Services Research in Primary Care, Veterans Affairs Medical Center, Durham, North Carolina, USA.
Pharmacotherapy. 1998 Mar-Apr;18(2):327-32.
We estimated the cost and cost-effectiveness of a clinical pharmacist intervention known to improve the appropriateness of drug prescribing. Elderly veteran outpatients prescribed at least five drugs were randomized to an intervention (105 patients) or control (103) group and followed for 1 year. The intervention pharmacist provided advice to patients and their physicians during all general medicine visits. Mean fixed and variable costs/intervention patient were $36 and $84, respectively Health services use and costs were comparable between groups. Intervention costs ranged from $7.50-30/patient/unit change in drug appropriateness. The cost to improve the appropriateness of drug prescribing is thus relatively low.
我们估算了一种已知可提高药物处方合理性的临床药师干预措施的成本及成本效益。为至少开具了五种药物的老年退伍军人门诊患者随机分组，105名患者进入干预组，103名患者进入对照组，并随访1年。干预组药师在所有普通内科就诊期间为患者及其医生提供建议。每名接受干预的患者的平均固定成本和可变成本分别为36美元和84美元。两组之间的医疗服务使用情况和成本具有可比性。干预成本为每位患者每单位药物合理性变化7.50 - 30美元。因此，提高药物处方合理性的成本相对较低。
